Publication

The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Ignacio F. Mata, Veterans Affairs Puget Sound Health Care SystemYongwoo Jang, Harvard Medical SchoolChun-Hyung Kim, Harvard Medical SchoolDavid S. Hanna, University of WashingtonMichael O. Dorschner, University of WashingtonAli Samii, Veterans Affairs Puget Sound Health Care SystemPinky Agarwal, Evergreen Hospital Medical CenterJohn W. Roberts, Virginia Mason Medical CenterOlga Klepitskaya, University of ColoradoDavid R. Shprecher, University of UtahKathryn A. Chung, Portland Veterans Affairs Medical CenterStewart Factor, Emory UniversityAlberto J. Espay, University of CincinnatiFredy J. Revilla, University of South CarolinaDonald S. Higgins, Samuel Stratton Veterans Affairs Medical CenterIrene Litvan, University of CaliforniaJames B. Leverenz, Cleveland ClinicDora Yearout, Emory UniversityMiguel Inca-Martinez, Instituto Nacional de Ciencias NeurologicasErica Martinez, Emory UniversityTiffany R. Thompson, Veterans Affairs Puget Sound Health Care SystemBrenna A. Cholerton, University of South CarolinaShu-Ching Hu, Veterans Affairs Puget Sound Health Care SystemKaren L. Edwards, University of CaliforniaKwang-Soo Kim, Harvard Medical SchoolCyrus P. Zabetian, Veterans Affairs Puget Sound Health Care System
Language
  • English
Date
  • 2015-12
Publisher
  • BioMed Central
Publication Version
Copyright Statement
  • © 2015 Mata et al.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1750-1326
Volume
  • 10
Issue
  • 1
Grant/Funding Information
  • A gift from the Dolsen Foundation.
  • This work was supported by grants from the National Institutes of Health (P50 NS062684, R01 NS065070, R01 NS084869) and the Department of Veterans Affairs (1I01BX000531)
Supplemental Material (URL)
Abstract
  • Objective To identify the causal gene in a multi-incident U.S. kindred with Parkinson’s disease (PD). Methods We characterized a family with a classical PD phenotype in which 7 individuals (5 males and 2 females) were affected with a mean age at onset of 46.1 years (range, 29-57 years). We performed whole exome sequencing on 4 affected and 1 unaffected family members. Sanger-sequencing was then used to verify and genotype all candidate variants in the remainder of the pedigree. Cultured cells transfected with wild-type or mutant constructs were used to characterize proteins of interest. Results We identified a missense mutation (c.574G > A; p.G192R) in the RAB39B gene that closely segregated with disease and exhibited X-linked dominant inheritance with reduced penetrance in females. The mutation occurred in a highly conserved amino acid residue and was not observed among 87,725 X chromosomes in the Exome Aggregation Consortium dataset. Sequencing of the RAB39B coding region in 587 familial PD cases yielded two additional mutations (c.428C > G [p.A143G] and c.624_626delGAG [p.R209del]) that were predicted to be deleterious in silico but occurred in families that were not sufficiently informative to assess segregation with disease. Experiments in PC12 and SK-N-BE(2)C cells demonstrated that p.G192R resulted in mislocalization of the mutant protein, possibly by altering the structure of the hypervariable C-terminal domain which mediates intracellular targeting. Conclusions Our findings implicate RAB39B, an essential regulator of vesicular-trafficking, in clinically typical PD. Further characterization of normal and aberrant RAB39B function might elucidate important mechanisms underlying neurodegeneration in PD and related disorders.
Author Notes
Research Categories
  • Psychology, General
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items